The evolution of “No Evidence of Disease Activity” in multiple sclerosis-Reference-Cited by-同舟云学术

The evolution of “No Evidence of Disease Activity” in multiple sclerosis

Published:2018-02 Issue: Volume:20 Page:231-238
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Lu G.,Beadnall H.N.,Barton J.,Hardy T.A.,Wang C.,Barnett M.H.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference111 articles.

1. Taís pais resende benevides, arielle kirmse, joao gabriel dib, henrique cal, marco orsini & lucas asiêro raujo. No evidence of disease activity in multiple sclerosis patients;André Palma da Cunha Matta;Expert Rev. Neurother.,2016

2. Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis;Arnold;BMC Neurol.,2014

3. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial;Arnold;BMC Neurol.,2017

4. The clinico-radiological paradox in multiple sclerosis revisited;Barkhof;Curr. Opin. Neurol.,2002

5. Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?;Bevan;JAMA Neurol.,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Validation of Coregistration and Structured Reporting for Magnetic Resonance Imaging Monitoring in Multiple Sclerosis;Journal of Computer Assisted Tomography;2024-07-30

2. Extended interval dosing with ocrelizumab in multiple sclerosis;Multiple Sclerosis Journal;2024-04-22

3. Prediction of disease activity and treatment failure in relapsing–remitting MS patients initiating daily oral DMTs;Multiple Sclerosis Journal;2024-03-29

4. Elevated plasma neurofilament light chain in immune-mediated neurological disorders (IMND) detected by immunomagnetic reduction (IMR);Brain Research;2023-12

5. A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis;npj Digital Medicine;2023-10-19